## **Core Concept**
Thrombolytic therapy is a treatment for acute myocardial infarction (AMI) aimed at dissolving the occluding coronary thrombus, thereby restoring blood flow to the ischemic myocardium. The timely administration of thrombolytics is critical for their effectiveness. The benefit of thrombolytics in reducing mortality is time-dependent.

## **Why the Correct Answer is Right**
The correct answer, , indicates that thrombolytics can provide a relative mortality reduction in the treatment of acute myocardial infarction if the patient presents within 12 hours of symptom onset. This is because the earlier the thrombolytic therapy is administered after the onset of AMI, the better the outcome. The greatest benefit is seen when thrombolytics are given within the first 2-3 hours, but there is still a significant benefit when given up to 12 hours after symptom onset. This benefit is attributed to the salvage of ischemic myocardium and the reduction of infarct size.

## **Why Each Wrong Option is Incorrect**
* **Option A:** is too early and, while early treatment is beneficial, specifying "within 2 hours" does not capture the full window of benefit as effectively as the correct answer.
* **Option B:** is within the beneficial timeframe but does not specify the full range as accurately as the correct answer.
* **Option D:** exceeds the generally recommended time frame for thrombolytic therapy in AMI. Administering thrombolytics beyond 24 hours may not provide significant benefit and could increase the risk of complications.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that "time is muscle" in the context of AMI; the sooner reperfusion is achieved (either with thrombolytics or primary PCI), the better the outcome. The American College of Cardiology/American Heart Association guidelines emphasize the importance of rapid evaluation and treatment of patients with AMI.

## **Correct Answer:** .